COVID-19 Impact on Global Novel Drug Delivery Systems in Cancer Therapy Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: C1C2440A7381EN
QYResearch

Abstracts

This report focuses on the global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Novel Drug Delivery Systems in Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Teva
• Johnson & Johnson
• Roche
• Takeda
• AbbVie
• Samyang Biopharmaceuticals
• Celgene
• Spectrum Pharmaceuticals, Inc.
• Gilead Sciences
• Shire (Baxalta)
• Merrimack

Market segment by Type, the product can be split into

• Nanoparticles
• Liquid Embolics
• Embolization Particles

Market segment by Application, split into

• Hospitals & Clinic
• Cancer Treatment Centers
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Novel Drug Delivery Systems in Cancer Therapy status, future forecast, growth opportunity, key market and key players.
• To present the Novel Drug Delivery Systems in Cancer Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Novel Drug Delivery Systems in Cancer Therapy are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Novel Drug Delivery Systems in Cancer Therapy Revenue
1.4 Market Analysis by Type
  1.4.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Nanoparticles
  1.4.3 Liquid Embolics
  1.4.4 Embolization Particles
1.5 Market by Application
  1.5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals & Clinic
  1.5.3 Cancer Treatment Centers
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Novel Drug Delivery Systems in Cancer Therapy Industry Impact
  1.6.1 How the Covid-19 is Affecting the Novel Drug Delivery Systems in Cancer Therapy Industry
    1.6.1.1 Novel Drug Delivery Systems in Cancer Therapy Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Novel Drug Delivery Systems in Cancer Therapy Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Novel Drug Delivery Systems in Cancer Therapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Novel Drug Delivery Systems in Cancer Therapy Market Perspective (2015-2026)
2.2 Novel Drug Delivery Systems in Cancer Therapy Growth Trends by Regions
  2.2.1 Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Novel Drug Delivery Systems in Cancer Therapy Historic Market Share by Regions (2015-2020)
  2.2.3 Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Novel Drug Delivery Systems in Cancer Therapy Market Growth Strategy
  2.3.6 Primary Interviews with Key Novel Drug Delivery Systems in Cancer Therapy Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Market Size
  3.1.1 Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Revenue (2015-2020)
  3.1.2 Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Players (2015-2020)
  3.1.3 Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio
  3.2.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Novel Drug Delivery Systems in Cancer Therapy Revenue in 2019
3.3 Novel Drug Delivery Systems in Cancer Therapy Key Players Head office and Area Served
3.4 Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service
3.5 Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Novel Drug Delivery Systems in Cancer Therapy Historic Market Size by Type (2015-2020)
4.2 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Type (2021-2026)

5 NOVEL DRUG DELIVERY SYSTEMS IN CANCER THERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)
5.2 Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
6.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in North America (2019-2020)
6.3 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
6.4 North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
7.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Europe (2019-2020)
7.3 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
7.4 Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

8 CHINA

8.1 China Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
8.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in China (2019-2020)
8.3 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
8.4 China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
9.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Japan (2019-2020)
9.3 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
9.4 Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
10.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

11 INDIA

11.1 India Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
11.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in India (2019-2020)
11.3 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
11.4 India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size (2015-2020)
12.2 Novel Drug Delivery Systems in Cancer Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020)
12.4 Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Teva
  13.1.1 Teva Company Details
  13.1.2 Teva Business Overview and Its Total Revenue
  13.1.3 Teva Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.1.4 Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020))
  13.1.5 Teva Recent Development
13.2 Johnson & Johnson
  13.2.1 Johnson & Johnson Company Details
  13.2.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.2.3 Johnson & Johnson Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.2.4 Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.2.5 Johnson & Johnson Recent Development
13.3 Roche
  13.3.1 Roche Company Details
  13.3.2 Roche Business Overview and Its Total Revenue
  13.3.3 Roche Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.3.4 Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.3.5 Roche Recent Development
13.4 Takeda
  13.4.1 Takeda Company Details
  13.4.2 Takeda Business Overview and Its Total Revenue
  13.4.3 Takeda Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.4.4 Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.4.5 Takeda Recent Development
13.5 AbbVie
  13.5.1 AbbVie Company Details
  13.5.2 AbbVie Business Overview and Its Total Revenue
  13.5.3 AbbVie Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.5.4 AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.5.5 AbbVie Recent Development
13.6 Samyang Biopharmaceuticals
  13.6.1 Samyang Biopharmaceuticals Company Details
  13.6.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Samyang Biopharmaceuticals Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.6.4 Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.6.5 Samyang Biopharmaceuticals Recent Development
13.7 Celgene
  13.7.1 Celgene Company Details
  13.7.2 Celgene Business Overview and Its Total Revenue
  13.7.3 Celgene Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.7.4 Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.7.5 Celgene Recent Development
13.8 Spectrum Pharmaceuticals, Inc.
  13.8.1 Spectrum Pharmaceuticals, Inc. Company Details
  13.8.2 Spectrum Pharmaceuticals, Inc. Business Overview and Its Total Revenue
  13.8.3 Spectrum Pharmaceuticals, Inc. Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.8.4 Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.8.5 Spectrum Pharmaceuticals, Inc. Recent Development
13.9 Gilead Sciences
  13.9.1 Gilead Sciences Company Details
  13.9.2 Gilead Sciences Business Overview and Its Total Revenue
  13.9.3 Gilead Sciences Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.9.4 Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.9.5 Gilead Sciences Recent Development
13.10 Shire (Baxalta)
  13.10.1 Shire (Baxalta) Company Details
  13.10.2 Shire (Baxalta) Business Overview and Its Total Revenue
  13.10.3 Shire (Baxalta) Novel Drug Delivery Systems in Cancer Therapy Introduction
  13.10.4 Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  13.10.5 Shire (Baxalta) Recent Development
13.11 Merrimack
  10.11.1 Merrimack Company Details
  10.11.2 Merrimack Business Overview and Its Total Revenue
  10.11.3 Merrimack Novel Drug Delivery Systems in Cancer Therapy Introduction
  10.11.4 Merrimack Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
  10.11.5 Merrimack Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Novel Drug Delivery Systems in Cancer Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Novel Drug Delivery Systems in Cancer Therapy Revenue
Table 3. Ranking of Global Top Novel Drug Delivery Systems in Cancer Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Nanoparticles
Table 6. Key Players of Liquid Embolics
Table 7. Key Players of Embolization Particles
Table 8. COVID-19 Impact Global Market: (Four Novel Drug Delivery Systems in Cancer Therapy Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Novel Drug Delivery Systems in Cancer Therapy Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Novel Drug Delivery Systems in Cancer Therapy Players to Combat Covid-19 Impact
Table 13. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2015-2020)
Table 17. Global Novel Drug Delivery Systems in Cancer Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Novel Drug Delivery Systems in Cancer Therapy Market Growth Strategy
Table 23. Main Points Interviewed from Key Novel Drug Delivery Systems in Cancer Therapy Players
Table 24. Global Novel Drug Delivery Systems in Cancer Therapy Revenue by Players (2015-2020) (Million US$)
Table 25. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Players (2015-2020)
Table 26. Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019)
Table 27. Global Novel Drug Delivery Systems in Cancer Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Novel Drug Delivery Systems in Cancer Therapy Product Solution and Service
Table 30. Date of Enter into Novel Drug Delivery Systems in Cancer Therapy Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 33. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Type (2015-2020)
Table 34. Global Novel Drug Delivery Systems in Cancer Therapy Revenue Market Share by Type (2021-2026)
Table 35. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Application (2015-2020)
Table 36. Global Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 37. Global Novel Drug Delivery Systems in Cancer Therapy Market Size Share by Application (2021-2026)
Table 38. North America Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 40. North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 41. North America Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 42. North America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 43. North America Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 44. Europe Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 46. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 48. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 50. China Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 51. China Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 52. China Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 53. China Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 54. China Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 55. China Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 56. Japan Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 58. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 60. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 64. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 66. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 68. India Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 69. India Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 70. India Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 71. India Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 72. India Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 73. India Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Novel Drug Delivery Systems in Cancer Therapy Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Novel Drug Delivery Systems in Cancer Therapy Market Share (2019-2020)
Table 76. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Share by Type (2015-2020)
Table 78. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Share by Application (2015-2020)
Table 80. Teva Company Details
Table 81. Teva Business Overview
Table 82. Teva Product
Table 83. Teva Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 84. Teva Recent Development
Table 85. Johnson & Johnson Company Details
Table 86. Johnson & Johnson Business Overview
Table 87. Johnson & Johnson Product
Table 88. Johnson & Johnson Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 89. Johnson & Johnson Recent Development
Table 90. Roche Company Details
Table 91. Roche Business Overview
Table 92. Roche Product
Table 93. Roche Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 94. Roche Recent Development
Table 95. Takeda Company Details
Table 96. Takeda Business Overview
Table 97. Takeda Product
Table 98. Takeda Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 99. Takeda Recent Development
Table 100. AbbVie Company Details
Table 101. AbbVie Business Overview
Table 102. AbbVie Product
Table 103. AbbVie Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 104. AbbVie Recent Development
Table 105. Samyang Biopharmaceuticals Company Details
Table 106. Samyang Biopharmaceuticals Business Overview
Table 107. Samyang Biopharmaceuticals Product
Table 108. Samyang Biopharmaceuticals Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 109. Samyang Biopharmaceuticals Recent Development
Table 110. Celgene Company Details
Table 111. Celgene Business Overview
Table 112. Celgene Product
Table 113. Celgene Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 114. Celgene Recent Development
Table 115. Spectrum Pharmaceuticals, Inc. Business Overview
Table 116. Spectrum Pharmaceuticals, Inc. Product
Table 117. Spectrum Pharmaceuticals, Inc. Company Details
Table 118. Spectrum Pharmaceuticals, Inc. Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 119. Spectrum Pharmaceuticals, Inc. Recent Development
Table 120. Gilead Sciences Company Details
Table 121. Gilead Sciences Business Overview
Table 122. Gilead Sciences Product
Table 123. Gilead Sciences Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 124. Gilead Sciences Recent Development
Table 125. Shire (Baxalta) Company Details
Table 126. Shire (Baxalta) Business Overview
Table 127. Shire (Baxalta) Product
Table 128. Shire (Baxalta) Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 129. Shire (Baxalta) Recent Development
Table 130. Merrimack Company Details
Table 131. Merrimack Business Overview
Table 132. Merrimack Product
Table 133. Merrimack Revenue in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020) (Million US$)
Table 134. Merrimack Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Type: 2020 VS 2026
Figure 2. Nanoparticles Features
Figure 3. Liquid Embolics Features
Figure 4. Embolization Particles Features
Figure 5. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospitals & Clinic Case Studies
Figure 7. Cancer Treatment Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Novel Drug Delivery Systems in Cancer Therapy Report Years Considered
Figure 10. Global Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions: 2020 VS 2026
Figure 12. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Novel Drug Delivery Systems in Cancer Therapy Market Share by Players in 2019
Figure 15. Global Top Novel Drug Delivery Systems in Cancer Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Novel Drug Delivery Systems in Cancer Therapy as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Novel Drug Delivery Systems in Cancer Therapy Revenue in 2019
Figure 17. North America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Novel Drug Delivery Systems in Cancer Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Teva Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 26. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Johnson & Johnson Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 28. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Roche Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 30. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Takeda Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 32. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. AbbVie Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 34. Samyang Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Samyang Biopharmaceuticals Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 36. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Celgene Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 38. Spectrum Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 40. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Gilead Sciences Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 42. Shire (Baxalta) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Shire (Baxalta) Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 44. Merrimack Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Merrimack Revenue Growth Rate in Novel Drug Delivery Systems in Cancer Therapy Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed